Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Osteoporosis International
Erschienen in:

08.08.2023 | Original Article

Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults

verfasst von: Da Hea Seo, Yujin Jeong, Yongin Cho, So Hun Kim, Seongbin Hong, Young Ju Suh, Seong Hee Ahn

Erschienen in: Osteoporosis International | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Summary

Previous studies have revealed the protective effects of statins on bone but the association of statins use with osteoporosis-related measurement has shown controversial results. In this study, we found an age, dose andduration–dependent osteoprotective effect of statins in general older population.

Purpose

Previous studies have revealed the protective effects of statins on bone but the association of statins use with osteoporotic fractures has shown controversial results.

Methods

In this study with Korean National Health Insurance Service-Senior cohort database, a total of 365,656 elderly without previous history of osteoporosis and who were started on statin since January 1 2004 were included and observed until December 31 2012. Hazard rations (HR) for major osteoporotic fractures were calculated using the weighted Cox proportional hazards model with inverse-probability of treatment weighting method.

Results

During 6.27 years of follow-up period, 54,959 osteoporotic fractures occurred and the majority of fractures (69.5%) were vertebral fractures. Compared with non-users, statin use was associated with a decreased risk of all outcomes with adjusted HR (95% CI) of 0.77 (0.72–0.83; P < 0.001) for major osteoporotic fractures, 0.49 (0.38–0.62; P < 0.001) for hip fractures, and 0.70 (0.64–0.77; P < 0.001) for vertebral fractures. When outcomes were examined separately by sex, the results were broadly comparable in terms of patterns of risk reduction by statin use. The patients with statin initiated at age ≥ 80 years had the highest risk reduction for most outcomes relative to non-users. Higher cumulative dose of statin was negatively associated with the osteoporotic fracture risk; 0.97 (0.91–1.02) for 30–364 cumulative daily defined dose (cDDD), 0.45 (0.40–0.51) for 365–1,094 cDDD, and 0.22 (0.15–0.33) for ≥ 1,095 cDDD.

Conclusions

Our results showed that statin use was associated with significant reduction in the risk of osteoporotic fractures in general older population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
(2000) Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement 17:1–45
2.
Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ 3rd (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Mineral Res 29:581–589CrossRef
3.
Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet (London, England) 359:1761–1767CrossRefPubMed
4.
Catapano AL, Graham I, De Backer G et al (2016) 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37:2999–3058CrossRefPubMed
5.
6.
Liu J, Zhu LP, Yang XL, Huang HL, Ye DQ (2013) HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis. Bone 54:151–156CrossRefPubMed
7.
Wang Z, Li Y, Zhou F, Piao Z, Hao J (2016) Effects of statins on bone mineral density and fracture risk: a prisma-compliant systematic review and meta-analysis. Medicine (Baltimore) 95:e3042CrossRefPubMed
8.
An T, Hao J, Sun S, Li R, Yang M, Cheng G, Zou M (2017) Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int 28:47–57CrossRefPubMed
9.
Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Ensrud KE, van der Klift M, Pols HAP (2004) Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med 164:146–152CrossRefPubMed
10.
Helin-Salmivaara A, Korhonen MJ, Lehenkari P, Junnila SY, Neuvonen PJ, Ruokoniemi P, Huupponen R (2012) Statins and hip fracture prevention–a population based cohort study in women. Plos One 7:e48095CrossRefPubMedPubMedCentral
11.
LaCroix AZ, Cauley JA, Pettinger M et al (2003) Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women’s Health Initiative Observational Study. Ann Intern Med 139:97–104CrossRefPubMed
12.
Lin TK, Liou YS, Lin CH, Chou P, Jong GP (2018) High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study. Clin Epidemiol 10:159–165CrossRefPubMedPubMedCentral
13.
14.
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946–1949CrossRefPubMed
15.
Wang PS, Solomon DH, Mogun H, Avorn J (2000) HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283:3211–3216CrossRefPubMed
16.
17.
Wertheimer AI (1986) The defined daily dose system (DDD) for drug utilization review. Hosp Pharm 21:233–234, 239–241, 258
18.
Jung HS, Nho JH, Ha YC, Jang S, Kim HY, Yoo JI, Park SM, Lee YK (2019) Incidence of osteoporotic refractures following proximal humerus fractures in adults aged 50 years and older in korea. J Bone Metab 26:105–111CrossRefPubMedPubMedCentral
19.
Park SM, Ahn SH, Kim HY, Jang S, Ha YC, Lee YK, Chung HY (2020) Incidence and mortality of subsequent vertebral fractures: analysis of claims data of the Korea National Health Insurance Service from 2007 to 2016. The Spine J 20:225–233CrossRefPubMed
20.
Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel JM, Sundararajan V (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682CrossRefPubMed
21.
Prentice RL, Kalbfleisch JD, Peterson AV Jr, Flournoy N, Farewell VT, Breslow NE (1978) The analysis of failure times in the presence of competing risks. Biometrics 34:541–554CrossRefPubMed
22.
Lin TK, Chou P, Lin CH, Hung YJ, Jong GP (2018) Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study. Plos One 13:e0196713CrossRefPubMedPubMedCentral
23.
Rea F, Bonassi S, Vitale C, Trifirò G, Cascini S, Roberto G, Chinellato A, Lucenteforte E, Mugelli A, Corrao G (2017) Exposure to statins is associated to fracture risk reduction in elderly people with cardiovascular disease: evidence from the AIFA-I-GrADE observational project. Pharmacoepidemiol Drug Saf 26:775–784CrossRefPubMed
24.
Cheng KC, Liao KF, Lin CL, Lin CC, Lai SW (2019) Case-control study examining the association between hip fracture risk and statins therapy in old people. Medicine (Baltimore) 98:e17476CrossRefPubMed
25.
Jin S, Jiang J, Bai P, Zhang M, Tong X, Wang H, Lu Y (2015) Statin use and risk of fracture: a meta-analysis. Int J Clin Exp Med 8:8269–8275PubMedPubMedCentral
26.
Wang Z, Li Y, Zhou F, Piao Z, Hao J (2016) Effects of statins on bone mineral density and fracture risk: a prisma-compliant systematic review and meta-analysis. Medicine (Baltimore) 95:e3042–e3042CrossRefPubMed
27.
Schoofs MW, Sturkenboom MC, van der Klift M, Hofman A, Pols HA, Stricker BH (2004) HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Mineral Res 19:1525–1530CrossRef
28.
Pedersen TR, Kjekshus J (2000) Statin drugs and the risk of fracture. JAMA 284:1921–1922
29.
30.
Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Mineral Res 13:581–589CrossRef
31.
Tsubaki M, Satou T, Itoh T, Imano M, Yanae M, Kato C, Takagoshi R, Komai M, Nishida S (2012) Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. Mol Cell Endocrinol 361:219–231CrossRefPubMed
32.
33.
Sato T, Morita I, Murota S (1998) Involvement of cholesterol in osteoclast-like cell formation via cellular fusion. Bone 23:135–140CrossRefPubMed
34.
Anagnostis P, Florentin M, Livadas S, Lambrinoudaki I, Goulis DG (2022) Bone health in patients with dyslipidemias: an underestimated aspect. Int J Mol Sci 23
35.
Rosen CJ, Bouxsein ML (2006) Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2:35–43CrossRefPubMed
36.
Perrien DS, Akel NS, Dupont-Versteegden EE, Skinner RA, Siegel ER, Suva LJ, Gaddy D (2007) Aging alters the skeletal response to disuse in the rat. Am J Physiol Regul Integr Comp Physiol 292:R988-996CrossRefPubMed
37.
Schwartz AV, Sigurdsson S, Hue TF et al (2013) Vertebral bone marrow fat associated with lower trabecular bmd and prevalent vertebral fracture in older adults. J Clin Endocrinol Metab 98:2294–2300CrossRefPubMedPubMedCentral
38.
Liu M, Wang K, Tang T, Dai K, Zhu Z (2009) The effect of simvastatin on the differentiation of marrow stromal cells from aging rats. Pharmazie 64:43–48PubMed
39.
Kim KJ, Choi J, Kim JY et al (2021) Statin therapy and the risk of osteoporotic fractures in patients with metabolic syndrome: a nested case-control study. J lipid Atheroscler 10:322–333CrossRefPubMedPubMedCentral
40.
Shi R, Mei Z, Zhang Z, Zhu Z (2019) Effects of statins on relative risk of fractures for older adults: an updated systematic review with meta-analysis. J Am Med Dir Assoc 20:1566-1578.e1563CrossRefPubMed
41.
Kim SH, Yi SW, Yi JJ, Kim YM, Won YJ (2018) Association between body mass index and the risk of hip fracture by sex and age: a prospective cohort study. J Bone Mineral Res 33:1603–1611CrossRef
42.
Du Puy RS, Poortvliet RKE, Snel M, den Elzen WPJ, Ballieux B, Dekkers OM, Mooijaart SP, Gussekloo J (2019) Associations of elevated antithyroperoxidase antibodies with thyroid function, survival, functioning, and depressive symptoms in the oldest old: the leiden 85-plus study. Thyroid 29:1201–1208CrossRefPubMed
Metadaten
Titel
Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults
verfasst von
Da Hea Seo
Yujin Jeong
Yongin Cho
So Hun Kim
Seongbin Hong
Young Ju Suh
Seong Hee Ahn
Publikationsdatum
08.08.2023
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 11/2023
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-023-06879-4

Weitere Artikel der Ausgabe 11/2023

Correction: Vitamin D status and clinical implications in the adult population of Malaysia: a position paper by the Malaysian Vitamin D Special Interest Group

  • Correction

The skeletal safety of milk-derived proteins: A meta-analysis of randomized controlled trials

  • Original Article

Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

  • Open Access
  • Correction

Milk intake and hip fracture incidence in community-dwelling old Icelandic adults

  • Original Article

Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

  • Open Access
  • Original Article

Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis

  • Open Access
  • Review

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie erweitert durch Fallbeispiele, Videos und Abbildungen. Zur Fortbildung und Wissenserweiterung, verfasst und geprüft von Expertinnen und Experten der Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA).


Jetzt entdecken!

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Leitlinienkonformes Management thermischer Verletzungen

Thermische Verletzungen gehören zu den schwerwiegendsten Traumen und hinterlassen oft langfristige körperliche und psychische Spuren. Die aktuelle S2k-Leitlinie „Behandlung thermischer Verletzungen im Kindesalter (Verbrennung, Verbrühung)“ bietet eine strukturierte Übersicht über das empfohlene Vorgehen.

Positive Daten für supraskapulären Nervenblock bei Schultersteife

Daten einer aktuellen Metaanalyse sprechen dafür, dass eine Blockade des Nervus suprascapularis bei Schultersteife mit Blick auf Funktion und Schmerzlinderung mindestens so effektiv ist wie eine Physiotherapie oder intraartikulär injizierte Steroide.

Wirbelgleiten: Dem persönlichen Drang zum Versteifen widerstehen!

In einer norwegischen Studie schnitt die alleinige Dekompressions-Op. bei Personen mit Wirbelgleiten auch dann nicht schlechter ab, wenn erfahrene Chirurgen/ Chirurginnen eigentlich für eine zusätzliche Versteifung plädiert hätten.

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise